References

Silent corticotroph adenomas

10.1007/s11102-018-0864-8 · 2018 · External reference

Clinical, radiological, and pathological characteristics and long-term outcomes of silent corticotroph adenomas: a retrospective study

10.1186/s12902-025-02115-8 · 2025 · External reference

Clinical and radiographic presentation and surgical outcomes of T-box pituitary transcription factor (TPIT) silent corticotroph pituitary neuroendocrine tumors: a multi-institutional experience and review of the literature

10.1016/j.wneu.2025.123791 · 2025 · External reference

Surgical outcomes of silent ACTH+ corticotroph pituitary neuroendocrine tumors: a multi-institutional experience and review of the literature

10.1227/neu.0000000000003512 · 2025 · External reference

The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3

10.1007/s12020-016-1028-0 · 2017 · External reference

Cell lineage-specific differences in clinical behavior of non-functioning pituitary adenomas

10.1210/clinem/dgaf112 · 2025 · External reference

Overview of the 2022 WHO classification of pituitary tumors

10.1007/s12022-022-09703-7 · 2022 · External reference

Clinical parameters of silent corticotroph adenomas with positive and negative adrenocorticotropic hormone immunostaining: a large retrospective single-center study of 105 cases

2020 · External reference

The 2022 WHO classification of tumors of the pituitary gland: an update on aggressive and metastatic pituitary neuroendocrine tumors

10.1111/bpa.13302 · 2025 · External reference

ACTH adenomas transforming their clinical expression: report of 5 cases

10.3171/2014.11.focus14679 · 2015 · External reference

Clinical, laboratory, and treatment profiles of silent corticotroph adenomas that have transformed to the functional type: a case series with a literature review

10.3389/fendo.2020.558593 · 2020 · External reference

Two distinctive POMC promoters modify gene expression in Cushing disease

10.1210/clinem/dgab387 · 2021 · External reference